Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Nutriband Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
NTRB
Nasdaq
2830
www.nutriband.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Nutriband Inc.
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
- Feb 7th, 2025 1:45 pm
Why Nutriband Inc (NTRB) Is Skyrocketing So Far In 2025
- Feb 4th, 2025 12:10 am
Shareholders in Nutriband (NASDAQ:NTRB) are in the red if they invested five years ago
- Jan 8th, 2025 3:10 pm
Nutriband Issues Letter to Shareholders
- Dec 31st, 2024 12:00 pm
Nutriband extends Chinese patent to Macao for AVERSA technology
- Dec 28th, 2024 2:30 pm
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
- Dec 27th, 2024 2:25 pm
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
- Dec 4th, 2024 2:00 pm
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th
- Dec 4th, 2024 12:00 pm
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
- Nov 27th, 2024 12:00 pm
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application
- Oct 31st, 2024 12:35 pm
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
- Oct 17th, 2024 11:00 am
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17
- Oct 2nd, 2024 11:00 am
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology
- Sep 24th, 2024 11:00 am
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
- Sep 20th, 2024 10:50 am
Nutriband Inc. Authorizes $1M Share Buyback Program
- Sep 16th, 2024 8:00 pm
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
- Sep 4th, 2024 11:00 am
Nutriband (NASDAQ:NTRB investor five-year losses grow to 80% as the stock sheds US$27m this past week
- Aug 1st, 2024 2:33 pm
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
- Jul 19th, 2024 11:00 am
Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology
- Jul 15th, 2024 11:00 am
Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
- Jun 20th, 2024 11:00 am
Scroll